Hostname: page-component-848d4c4894-nr4z6 Total loading time: 0 Render date: 2024-05-01T12:01:49.303Z Has data issue: false hasContentIssue false

259 Eighty-six-fold increase in HIV diagnosis with “Opt-out” Screening: Frontlines of Communities in the U.S. (FOCUS) Program in the UHealth Tower (UHT) Emergency Department (ED) - path to eliminate HIV transmission in the U.S.

Published online by Cambridge University Press:  03 April 2024

Dushyantha Jayaweera
Affiliation:
University of Miami
Yaa F. Abu
Affiliation:
Department of Medicine, University of Miami, Miami, FL, USA
Barbara Huang
Affiliation:
Department of Medicine, University of Miami, Miami, FL, USA
Emmanuel Thomas
Affiliation:
Department of Medicine, University of Miami, Miami, FL, USA
David M. Lang
Affiliation:
Department of Medicine, University of Miami, Miami, FL, USA
Tanira Ferreira
Affiliation:
Department of Medicine, University of Miami, Miami, FL, USA
Kimar Estes
Affiliation:
Department of Medicine, University of Miami, Miami, FL, USA
Monica Bahamon
Affiliation:
Department of Medicine, University of Miami, Miami, FL, USA
Paula Pagan
Affiliation:
Department of Medicine, University of Miami, Miami, FL, USA
Kira Villamizar
Affiliation:
Department of Health, Miami Dade County, FL, USA
Kenneth A Scheppke
Affiliation:
Department of Health, Tallahassee, FL, USA
Dushyantha Jayaweera
Affiliation:
Department of Medicine, University of Miami, Miami, FL, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

OBJECTIVES/GOALS: Early HIV detection and treatment are key to reducing patient morbidity and mortality, yet 40% of people living with HIV do not know their status. “OPT-OUT” approaches to hiv testing, in which patients #_MSOCOM_1 are informed that an HIV test will be conducted unless they decline, are being increasingly recognized as a means to increase HIV testing. METHODS/STUDY POPULATION: the ed at Uhealth tower (UHT) implemented #_MSOCOM_1 the focus program that integrates routine “opt-out” HIV screening into the existing electronic medical record workflow to increase the number of individuals who know their HIV status, optimize linkage to care, and reduce stigma associated with HIV. the emr facilitates the opt-out screening model and maximizes the use of information systems to seamlessly integrate screening as a routine practice in a high-volume ed. our partnership with the florida department of health in miami dade (FDOH) allows uht to verify whether cases are new or known /out-of-care, link individuals immediately to care, and increase efficiencies with real-time data reconciliation. RESULTS/ANTICIPATED RESULTS: since implementation#_MSOCOM_1, from October 2019 - Dec 2022, the UHT ED screened 34, 314 eligible patients for HIV, of which, 17, 850 were tested. 228 people with hiv were identified; 37 were newly diagnosed. of HIV+ Diagnoses, 54.67% of HIV+ individuals were black and 36.89% HISPANIC. HIV+ individuals were referred to the doh with linkage to care at 81%. comparatively, before the onset of focus, the ED ordered 38 HIV tests, with one positive from Oct 2018 TO Sept. 2019. DISCUSSION/SIGNIFICANCE: UHT ED’s focus “OPT-OUT” HIV testing is a valuable conduit for HIV detection, prevention, and care. OPT-OUT screening removes the stigma associated with hiv testing, fosters earlier diagnoses and treatment, reduces health disparities, and decreases the risk of transmission.

Type
Health Equity and Community Engagement
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
© The Author(s), 2024. The Association for Clinical and Translational Science